SMTL ID : 3ka0.1

MK2 complex with inhibitor 6-(5-(2-aminopyrimidin-4-ylamino)-2-hydroxyphenyl)-N-methylbenzo[b]thiophene-2-carboxamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

monomer

Ligands

1 x MK3: 6-{5-[(2-aminopyrimidin-4-yl)amino]-2-hydroxyphenyl}-N-methylidene-1-benzothiophene-2-carboxamide(Non-covalent)

MK3.1: 14 residues within 4Å: Chain A: V.32, Q.34, K.43, A.45, K.47, H.62, M.92, E.93, C.94, L.95, D.96, L.147, T.160, D.161 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.32, A:V.32, A:L.147 Hydrogen bonds: A:Q.34, A:K.43, A:K.47, A:L.95, A:D.161 Water bridges: A:K.47, A:F.162 Salt bridges: A:D.161

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Argiriadi, M.A. et al., 2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-01-12

Peptides

MAP kinase-activated protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

MAP kinase-activated protein kinase 2